Smart jab can shrink head and neck cancer tumours within six weeks, trial finds
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers Doctors have hailed “incredibly encouraging” trial results that show a triple-action smart jab can shrink tumours in head and neck cancer patients within six weeks. Head and neck (…)
Site référencé:
The Guardian (South&CentralAsia)
3566.jpg?width=140&quality=85&auto=format&fit=max&s=6b8d8aa1d243e52630ec912240d7c64f, 3566.jpg?width=460&quality=85&auto=format&fit=max&s=2d87713509e54a6825bcd7efa979683a, 3566.jpg?width=700&quality=85&auto=format&fit=max&s=0f55e3e23cd4fdddf1f92afd52d64c83
The Guardian (South&CentralAsia)
Tech bros need the world to believe their hype. Here’s an idea – let’s just ignore them | Pip Finkemeyer
19/10/2025
Suspected scam investment firms ‘exploiting Trustpilot review system’
19/10/2025
Spirituality isn’t rigid dogma. It’s a living, breathing practice that helps make sense of an incomprehensible world | Shadi Khan Saif
19/10/2025
The rise of the sleep data nerds : ‘The harder you try, the harder it is to sleep’
19/10/2025
The kindness of strangers : a gang of scary-looking youths stepped in to save me from being mugged
19/10/2025
US couples are moving in together sooner to save money : ‘The world isn’t made for singles’
19/10/2025